Patient Capital Management LLC Takes Position in Crocs, Inc. $CROX

Patient Capital Management LLC acquired a new stake in shares of Crocs, Inc. (NASDAQ:CROX) in the 2nd quarter, HoldingsChannel reports. The institutional investor acquired 799,426 shares of the textile maker’s stock, valued at approximately $96,443,000. Crocs comprises approximately 3.2% of Patient Capital Management LLC’s investment portfolio, making the stock its 15th largest holding.

A number of other hedge funds and other institutional investors have also bought and sold shares of CROX. BlackRock Inc. bought a new position in Crocs in the 2nd quarter valued at $561,223,000. AQR Capital Management LLC increased its holdings in shares of Crocs by 399.0% in the third quarter. AQR Capital Management LLC now owns 1,266,799 shares of the textile maker’s stock worth $105,841,000 after purchasing an additional 1,012,943 shares during the period. Norges Bank bought a new position in shares of Crocs in the fourth quarter worth $67,545,000. Himalaya Capital Management LLC purchased a new stake in shares of Crocs in the fourth quarter worth $53,720,000. Finally, Fuller & Thaler Asset Management Inc. raised its position in shares of Crocs by 78.7% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 907,988 shares of the textile maker’s stock worth $77,651,000 after buying an additional 399,964 shares in the last quarter. Institutional investors own 93.44% of the company’s stock.

Analyst Upgrades and Downgrades

CROX has been the subject of several recent analyst reports. Barclays boosted their target price on Crocs from $110.00 to $118.00 and gave the stock an “equal weight” rating in a research report on Friday, July 31st. Weiss Ratings raised Crocs from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, August 13th. Bank of America lifted their price target on Crocs from $145.00 to $160.00 and gave the company a “buy” rating in a research report on Thursday, July 23rd. Seaport Research Partners boosted their price objective on Crocs from $135.00 to $160.00 and gave the stock a “buy” rating in a report on Monday, July 20th. Finally, Deutsche Bank Aktiengesellschaft started coverage on shares of Crocs in a research report on Monday, June 8th. They issued a “buy” rating on the stock. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, seven have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat, Crocs presently has a consensus rating of “Moderate Buy” and an average price target of $139.10.

Crocs Stock Performance

Shares of CROX stock opened at $122.11 on Monday. The company has a quick ratio of 0.96, a current ratio of 1.49 and a debt-to-equity ratio of 0.94. The business has a 50-day moving average price of $129.45 and a two-hundred day moving average price of $108.52. Crocs, Inc. has a 12-month low of $73.21 and a 12-month high of $141.28. The firm has a market cap of $5.85 billion, a P/E ratio of 10.55, a price-to-earnings-growth ratio of 1.02 and a beta of 1.53.

Crocs (NASDAQ:CROX) last announced its quarterly earnings data on Thursday, July 30th. The textile maker reported $4.55 EPS for the quarter, beating the consensus estimate of $4.35 by $0.20. The firm had revenue of $1.18 billion for the quarter, compared to analyst estimates of $1.15 billion. Crocs had a return on equity of 47.75% and a net margin of 14.64%.The company’s revenue was up 2.6% on a year-over-year basis. During the same period in the prior year, the company earned ($8.82) EPS. Crocs has set its FY 2026 guidance at 13.700-14.000 EPS and its Q3 2026 guidance at 3.200-3.300 EPS. Equities analysts anticipate that Crocs, Inc. will post 13.95 EPS for the current fiscal year.

Insiders Place Their Bets

In other Crocs news, CEO Andrew Rees sold 19,072 shares of the company’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $138.91, for a total value of $2,649,291.52. Following the completion of the sale, the chief executive officer owned 713,293 shares of the company’s stock, valued at $99,083,530.63. This represents a 2.60% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In the last ninety days, insiders sold 62,688 shares of company stock valued at $8,014,859. Insiders own 3.10% of the company’s stock.

Crocs Profile

Crocs, Inc is a global footwear designer, developer and distributor best known for its lightweight, proprietary Croslite™ foam-clog construction. The company’s product portfolio encompasses a range of styles, including clogs, sandals, slides, boots and sneakers, all featuring the slip-resistant, odor-resistant and cushion-providing qualities of the Croslite material. Crocs distributes its products through an omnichannel network that includes e-commerce platforms, company-owned retail stores, authorized dealers and wholesale partners.

Founded in 2002 by Scott Seamans, Lyndon “Duke” Hanson and George Boedecker Jr., Crocs launched its first clog on the island of Vail, Colorado.